203 related articles for article (PubMed ID: 1982561)
1. Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.
Semeraro C; Ferrini R; Allievi L; Pocchiari F; Nicosia S; Casagrande C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):539-46. PubMed ID: 1982561
[TBL] [Abstract][Full Text] [Related]
2. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
3. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.
Hjorth S; Carlsson A
J Neural Transm; 1988; 72(2):83-97. PubMed ID: 2968439
[TBL] [Abstract][Full Text] [Related]
4. The effect of dopamine on rat gastric motility.
Nagahata Y; Urakawa T; Kuroda H; Tomonaga K; Idei H; Kawakita N; Yoshizumi K; Saitoh Y
Gastroenterol Jpn; 1992 Aug; 27(4):482-7. PubMed ID: 1356091
[TBL] [Abstract][Full Text] [Related]
5. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
[TBL] [Abstract][Full Text] [Related]
6. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.
Kohli JD; Glock D; Goldberg LI
Eur J Pharmacol; 1983 Apr; 89(1-2):137-41. PubMed ID: 6861882
[TBL] [Abstract][Full Text] [Related]
7. [Effects of tetrahydroberberine on peripheral vascular dopamine DA1 and DA2 receptor subtypes].
Zhang WF; Zhi JM; Guo W; Zhao RR; Jin GZ
Zhongguo Zhong Yao Za Zhi; 2000 Aug; 25(8):497-500. PubMed ID: 12515216
[TBL] [Abstract][Full Text] [Related]
8. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
Nishiyama S; Yoshikawa M; Yamaguchi I
J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence for the presence of a peripheral postjunctional D2-like dopamine receptor in rabbit splenic artery.
Zanzottera D; Ferlenga P; Marchini F; Semeraro C
Br J Pharmacol; 1998 Feb; 123(4):730-6. PubMed ID: 9517393
[TBL] [Abstract][Full Text] [Related]
11. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.
Goldberg LI; Glock D; Kohli JD; Barnett A
Hypertension; 1984; 6(2 Pt 2):I25-30. PubMed ID: 6144634
[TBL] [Abstract][Full Text] [Related]
12. DA1 receptor mediates dopamine-induced relaxation of opossum lower esophageal sphincter in vitro.
Lombardi DM; Grous M; Fine CF; Barone FC; Fowler PJ; Phyall WB; Rush JA; Ormsbee HS
Gastroenterology; 1986 Sep; 91(3):533-9. PubMed ID: 2874097
[TBL] [Abstract][Full Text] [Related]
13. [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor.
Huo T; Healy DP
J Pharmacol Exp Ther; 1991 Aug; 258(2):424-8. PubMed ID: 1830902
[TBL] [Abstract][Full Text] [Related]
14. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
15. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
Harsing LG; Sershen H; Lajtha A
J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
[TBL] [Abstract][Full Text] [Related]
17. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Ensinger H; Majewski H; Hedler L; Starke K
J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors.
Bertorello A; Aperia A
Am J Physiol; 1990 Dec; 259(6 Pt 2):F924-8. PubMed ID: 1979719
[TBL] [Abstract][Full Text] [Related]
19. DA1 dopamine receptors in renal cortical collecting duct.
Ohbu K; Felder RA
Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
[TBL] [Abstract][Full Text] [Related]
20. Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion.
Glavin GB
J Pharmacol Exp Ther; 1989 Nov; 251(2):726-30. PubMed ID: 2530341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
